Biljana Mihaljević

[Primary gastrointestinal non-Hodgkin's lymphomas].

R Nedeljkov, Biljana Mihaljević, G Milivojević et al. · PubMed · 1993 · 169 citations

Lymphoid Neoplasia, Surgical Oncology, Gastrointestinal Oncology +15

Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial

Andrew Davies, Francesco Merli, Biljana Mihaljević et al. · The Lancet Haematology · 2017 · 112 citations

Lymphoid Neoplasia, Medicine, Follicular Lymphoma +5

Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study

Andrew Davies, Francesco Merli, Biljana Mihaljević et al. · The Lancet Oncology · 2014 · 111 citations

Lymphoid Neoplasia, Medicine, Randomised Phase 3 +7

Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial

Ulrich Jaeger, Marek Trněný, Helen Melzer et al. · Haematologica · 2015 · 83 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Rituximab Maintenance Therapy +14

Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients

Darko Antić, Nataša Milić, Srdjan Nikolovski et al. · American Journal of Hematology · 2016 · 83 citations · Full text

Prognosis, Logistic Analysis, Hematological Malignancy +24